NK1 Receptor Antagonist
978-613-1-94185-6
6131941858
120
2010-08-27
39,00 €
eng
https://images.our-assets.com/cover/230x230/9786131941856.jpg
https://images.our-assets.com/fullcover/230x230/9786131941856.jpg
https://images.our-assets.com/cover/2000x/9786131941856.jpg
https://images.our-assets.com/fullcover/2000x/9786131941856.jpg
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Neurokinin 1 (NK1) antagonists are a novel class of medications that possesses unique antidepressant, anxiolytic, and antiemetic properties. The discovery of neurokinin 1 (NK1) receptor antagonists was a turning point in the prevention of nausea and vomiting associated with cancer chemotherapy. An example of a drug in this class is aprepitant. Chemotherapy-induced emesis appears to consist of acute and delayed phases. So far the acute phase emesis responds to 5-HT3 antagonists while the delayed phase remains difficult to control. The discovery and development of NK1 receptor antagonists have elicited antiemetic effect in both acute and especially in delayed phases of emesis.
https://morebooks.de/books/hu/published_by/betascript-publishing/1/products
Gyógyszerészet
https://morebooks.de/store/hu/book/nk1-receptor-antagonist/isbn/978-613-1-94185-6